|
A spokesperson for the US Department of State told Pharmaceutical Technology that the “American people have paid more than enough” to the WHO.
|
 |
|
This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the upcoming patent cliff.
|
|
|
Corxel’s lead candidate, CX11, is currently in a Phase II trial in the US and a Phase III trial in China.
|
|
|
The approval is supported by data from the DESTINY-Gastric04 Phase III trial.
|
|
|
Deepanshu Saini, Director of Program Management at IQVIA reflects on the interplay between safety and AI pharmacovigilance.
|
|
